The two models are based on the somatic expression of the human oncogene HRASV12 in neural progenitor cells; the first model (called RAS) (Figure 1a, RAS) resembles the molecular mesenchymal subtype of glioblastoma [16] and uses ALT for telomere maintenance [20]. This evidence concerns the gene GPT and glioblastoma.